|
|
Volumn 38, Issue 1, 2016, Pages e4-
|
|
Comment: Analysis of the influence of dabigatran on coagulation factors and inhibitors
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACTIVATED PROTHROMBIN COMPLEX;
ANTICOAGULANT AGENT;
BLOOD CLOTTING FACTOR;
BLOOD CLOTTING FACTOR 5;
BLOOD CLOTTING FACTOR 8;
BLOOD CLOTTING FACTOR 9;
BLOOD CLOTTING INHIBITOR;
DABIGATRAN;
PROTHROMBIN;
RECOMBINANT BLOOD CLOTTING FACTOR 7A;
BLEEDING;
HUMAN;
LETTER;
PARTIAL THROMBOPLASTIN TIME;
PRIORITY JOURNAL;
TREATMENT INDICATION;
TREATMENT RESPONSE;
BLOOD;
BLOOD CLOTTING TEST;
FEMALE;
MALE;
STANDARDS;
BLOOD COAGULATION FACTOR INHIBITORS;
BLOOD COAGULATION FACTORS;
BLOOD COAGULATION TESTS;
DABIGATRAN;
FEMALE;
HUMANS;
MALE;
|
|
EID: 84954025779
PISSN: 17515521
EISSN: 1751553X
Source Type: Journal
DOI: 10.1111/ijlh.12439 Document Type: Letter |
|
Times cited : (2)
|
|
References (5)
|
